All lobbying filings
TIBER CREEK HEALTH STRATEGIES, INC.
TIBER CREEK HEALTH STRATEGIES, INC. filed a Q1 report for TIBER CREEK GROUP (ON BEHALF OF MERCK & CO INC) on April 17, 2025, reporting $50,000 in lobbying income.
Lobbying for TIBER CREEK GROUP (ON BEHALF OF MERCK & CO INC) · Prescription medicines, vaccines, and biologic therapies
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 17, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Government bodies contacted
1
Lobbying activity
1
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169).